期刊文献+

免疫抑制酸性蛋白单克隆抗体MI-2体外抗肿瘤作用的观察

Antitumor Activity of Monoclonal Antibody MI-2 Against Immunosuppressive Acidic Protein in Vitro
下载PDF
导出
摘要 作者采用MTT比色法观察了本室自制免疫抑制酸性蛋白单克隆抗体MI-2的体外抗肿瘤作用。结果表明:MI-2在浓度为7.81 μg/ml时即可明显抑制胃癌细胞株SGC 7901的生长(抑制率7.5%±2.4%,P<0.01),并见剂量依赖型表现;在LAK细胞与SGC 7901胃癌细胞的效靶比为10:1时,加入1.95 μg/ml的MI-2即可明显增强LAK细胞的细胞毒作用(增强效应为206.3%,P<0.01),也呈剂量依赖性表现。作者还发现MI-2的这种抗肿瘤作用与补体无关。 The in vitro antitumor activity of monoclonal antibody MI-2 against immuno-suppressive acidic protein (IAP)by our laboratory has been observed with MTT assay for cy-totoxicity. The results showed that the growth of human gastric cancer cell line SGC 7901 was inhibited significantly (P<0. 01)when MI-2 was added with 7. 81μg/ml or more. The inhibition activity of MI-2 appeared in a dose dependent manner. Increased cytotoxicity (up to 206. 3%)of LAK cells to SGC7901 could be remarkably (P<0. 01)induced by addition of 1. 95 μg/ml MI-2 when the ratio of effector to target was 10 : 1. The enhancing effect of MI-2 on LAK cell activity was also dose-dependent. The antitumor activity of MI-2 was not associated with human complements.
出处 《胃肠病学和肝病学杂志》 CAS 1993年第2期11-14,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 单克隆抗体 免疫抑制因子 淋巴因子激活杀伤细胞 细胞毒性 胃肿瘤 monclonal antibody lymphokine activated killer cells cytotoxicity gastric neoplasm.
  • 相关文献

参考文献2

  • 1田口铁男,董海东.继承性免疫治疗的最新进展[J].国际肿瘤学杂志,1991,30(6):327-329. 被引量:4
  • 2樊代明,杨开其,张学庸,陈希陶,牟震先,胡家露,乔太东,陈宝军,范平,田扬顺.免疫抑制酸性蛋白McAb的制备及免疫组化定位研究[J]上海免疫学杂志,1988(04).

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部